Concepedia

Author

Katarina Le Blanc

Karolinska University HospitalORCID

Also Known As

C Sylve, K L Blanc, K Le Blanc, K. Le Blanc, KATARINA LE BLANC, Katarina Blanc, Katarina Le Blanc, Katarina le Blanc, Le Blanc, Katarina

211

Publications

49K

Citations

74

H-Index

136

Concepts

All Affiliations

Karolinska University HospitalKarolinska InstitutetUppsala UniversityFriedrich-Alexander-Universität Erlangen-NürnbergLeiden University Medical Center
KL

About

Katarina Le Blanc is an author at Karolinska University Hospital specializing in medicine, cell transplantation, and stem cells.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

39

59

34.4K

2

Health Sciences

17

20

5K

3

Engineering

7

7

2.3K

4

Natural Sciences

2

2

45

5

Public Health

2

2

29

Katarina Le Blanc

×

112

Publications

42.8K

Citations

62

H-Index

YearCitations

Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement

Massimo Dominici, Katarina Le Blanc, Ingo Mueller,

Cytotherapy

2006

17.4K

Treatment of severe acute graft-versus-host disease with third party haploidentical mesenchymal stem cells

Katarina Le Blanc, Ida Rasmusson, Berit Sundberg,

The Lancet

2004

2.7K

Mesenchymal stem cells for treatment of steroid-resistant, severe, acute graft-versus-host disease: a phase II study

Katarina Le Blanc, Francesco Frassoni, Lynne M. Ball,

The Lancet

2008

2.7K

Clarification of the nomenclature for MSC: The International Society for Cellular Therapy position statement

E.M. Horwitz, Katarina Le Blanc, Massimo Dominici,

Cytotherapy

2005

2K

HLA expression and immunologic propertiesof differentiated and undifferentiated mesenchymal stem cells

Katarina Le Blanc, Charlotte Tammik, Kerstin Rosendahl,

Experimental Hematology

2003

1.6K

Extracellular vesicle in vivo biodistribution is determined by cell source, route of administration and targeting

Oscar P. B. Wiklander, Joel Z. Nordin, Aisling J. O’Loughlin,

Journal of Extracellular Vesicles

2015

1.6K

Mesenchymal Stem Cells Inhibit and Stimulate Mixed Lymphocyte Cultures and Mitogenic Responses Independently of the Major Histocompatibility Complex

Katarina Le Blanc, L Tammik, Berit Sundberg,

Scandinavian Journal of Immunology

2003

1.4K

Mesenchymal Stem Cells for Treatment of Therapy-Resistant Graft-versus-Host Disease

Olle Ringdén, Mehmet Uzunel, Ida Rasmusson,

Transplantation

2006

1.1K

Mesenchymal stem cells inhibit the formation of cytotoxic T lymphocytes, but not activated cytotoxic T lymphocytes or natural killer cells

Ida Rasmusson, Olle Ringdén, Berit Sundberg,

Transplantation

2003

661

Analysis of Tissues Following Mesenchymal Stromal Cell Therapy in Humans Indicates Limited Long-Term Engraftment and No Ectopic Tissue Formation

Lena von Bahr, Ioannis Batsis, Guido Moll,

Stem Cells

2012

560

Page 1